ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

ASRO President Tells Colleagues To Take Charge

October 26, 1990

Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge

March 27, 1981

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

Cigarette Smokers Are Dying Of Lung Cancer More Often Than Of Heart Disease, Study Finds

August 30, 1991

Public Should Be Warned About Smokeless tobacco Risks, Panel Says

January 24, 1986